Fundz
Real-time · AI · Cross-signal

Nordicus Partners Corporation just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Nordicus Partners Corporation, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Nordicus Partners Corporation Acquires Bio-Convert ApS

Nov 11, 2024•over 1 year ago

Contract Type

partnership

DenmarkBiotechnology

Description

Nordicus Partners Corporation has announced that it entered into an agreement with Bio-Convert ApS to acquire 100% of its shares outstanding for 12 million of the Company's restricted common shares in an all-stock transaction to the selling shareholders. Bio-Convert ApS is a Denmark-based clinical-stage biopharmaceutical company focused on revolutionizing the treatment of oral leukoplakia, and Nordicus Partners Corporation aims to support Bio-Convert's mission through this acquisition.

Company Information

Company

Nordicus Partners Corporation

Location

Denmark

About

Nordicus Partners Corporation is a Denmark-based financial consulting company, specializing in providing Nordic and U.S. life sciences companies with the best possible conditions to establish themselves on the U.S. market. Nordicus’ 95% owned subsidiary, Orocidin A/S, is a clinical-stage biopharmaceutical company which is advancing the next generation of periodontitis therapies. Nordicus’ core competencies lie in assisting Danish as well as other Nordic and international companies in different areas of corporate finance activities.

Predictive Intelligence
Strategic

ML-powered predictions for Nordicus Partners Corporation's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.